Biotech & pharma
New antibodies treat autoimmune disease in mice
28 Dec 2011
New personalised treatment options for cancer
28 Dec 2011
New light shed on chromosome fragility
27 Dec 2011
How bacteria fight fluoride in toothpaste and in nature
By By Bill Hathaway | 26 Dec 2011
Neuroscientists identify a master controller of memory
By By Anne Trafton, MIT News Office | 26 Dec 2011
Removable ‘cloak’ for nanoparticles helps target tumours
By By Anne Trafton, MIT News Office | 23 Dec 2011
A new type of drug-delivery nanoparticle that exploits a trait shared by almost all tumours — they are more acidic than healthy tissues — and can be used to deliver cancer drugs to nearly any type of tumour
Tissue structure delays cancer development
20 Dec 2011
Bioboost for biomass-based energy
17 Dec 2011
Spiral proteins are efficient gene delivery agents
By By Liz Ahlberg | 17 Dec 2011
Gene therapy achieves early success against haemophilia B
14 Dec 2011
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder
A glow of recognition
By By David L. Chandler, MIT News Office | 14 Dec 2011
Researchers design Alzheimer’s antibodies
13 Dec 2011
Body’s fat switch discovered
12 Dec 2011
Research could help people with declining sense of smell
By By Robert Sanders | 10 Dec 2011
Proteins linked to longevity may be involved in mood control
By By Anne Trafton, MIT News Office | 10 Dec 2011
Very-low-calorie diets provoke a comprehensive physiological response that promotes survival, all orchestrated by a set of proteins called sirtuins, which in excess can produce anxiety, a possible evolutionary adaptation to dietary restriction
Acquired traits can be inherited via small RNAs
08 Dec 2011
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
